TABLE OF CONTENTS
Volume 26, Issue 5 (1 February 2007)
Original Articles
Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoter
F L Delarue, J Adnane, B Joshi, M A Blaskovich, D-A Wang, J Hawker, F Bizouarn, J Ohkanda, K Zhu, A D Hamilton, S Chellappan and S M Sebti
Oncogene 26: 633-640; advance online publication, August 14, 2006; doi:10.1038/sj.onc.1209819
NF-
B activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage
S M Wuerzberger-Davis, Y Nakamura, B J Seufzer and S Miyamoto
Oncogene 26: 641-651; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209815
Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor
J An, A S Chervin, A Nie, H S Ducoff and Z Huang
Oncogene 26: 652-661; advance online publication, August 7, 2006; doi:10.1038/sj.onc.1209830
Kit and PDGFR-
activities are necessary for Notch4/Int3-induced tumorigenesis
A Raafat, A Zoltan-Jones, L Strizzi, S Bargo, K Kimura, D Salomon and R Callahan
Oncogene 26: 662-672; advance online publication, July 31, 2006; doi:10.1038/sj.onc.1209823
Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-
B activation in normal human bronchial epithelial cells
D N Syed, F Afaq, M-H Kweon, N Hadi, N Bhatia, V S Spiegelman and H Mukhtar
Oncogene 26: 673-682; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209829
RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer
P A Bignone, K Y Lee, Y Liu, G Emilion, J Finch, A E R Soosay, F M L Charnock, S Beck, I Dunham, A J Mungall and T S Ganesan
Oncogene 26: 683-700; advance online publication, July 31, 2006; doi:10.1038/sj.onc.1209827
Modulation of Nr-13 antideath activity by peptide aptamers
A-L Nouvion, J Thibaut, O D Lohez, S Venet, P Colas, G Gillet and P Lalle
Oncogene 26: 701-710; advance online publication, August 14, 2006; doi:10.1038/sj.onc.1209832
NF-
B represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2
H L Chua, P Bhat-Nakshatri, S E Clare, A Morimiya, S Badve and H Nakshatri
Oncogene 26: 711-724; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209808
A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts
R Mazzieri, F Furlan, S D'Alessio, E Zonari, F Talotta, P Verde and F Blasi
Oncogene 26: 725-732; advance online publication, July 31, 2006; doi:10.1038/sj.onc.1209833
Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells
I V Lebedeva, Z-Z Su, L Emdad, A Kolomeyer, D Sarkar, S Kitada, S Waxman, J C Reed and P B Fisher
Oncogene 26: 733-744; advance online publication, August 21, 2006; doi:10.1038/sj.onc.1209813
Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway
G P Amorino, P D Deeble and S J Parsons
Oncogene 26: 745-756; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209814
ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation
X Wu, S M Shell, Y Liu and Y Zou
Oncogene 26: 757-764; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209828
Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia
Y Wu, K McRoberts, S S Berr, H F Frierson Jr, M Conaway and D Theodorescu
Oncogene 26: 765-773; advance online publication, July 31, 2006; doi:10.1038/sj.onc.1209835
Short Communications
Differential effects of inactivated Axin1 and activated
-catenin mutations in human hepatocellular carcinomas
J Zucman-Rossi, S Benhamouche, C Godard, S Boyault, G Grimber, C Balabaud, A S Cunha, P Bioulac-Sage and C Perret
Oncogene 26: 774-780; advance online publication, September 11, 2006; doi:10.1038/sj.onc.1209824
Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction
S Baluchamy, N Sankar, A Navaraj, E Moran and B Thimmapaya
Oncogene 26: 781-787; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209825
Corrigenda
Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor FREE
S E Winograd-Katz and A Levitzki
Oncogene 26: 788; doi:10.1038/sj.onc.1210160
